EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Development and validation of a scoring system to predict mortality in patients hospitalized with COVID-19: A retrospective cohort study in two large hospitals in Ecuador

Iván Dueñas-Espín iD, María Echeverría-Mora, Camila Montenegro-Fárez, Manuel Baldeón, Luis Chantong Villacres, Hugo Espejo Cárdenas iD, Marco Fornasini, Miguel Ochoa Andrade iD, Carlos Solís

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0288106 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Iván Dueñas-Espín und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica del Ecuador (PUCE), Quito, Ecuador. Hauptthemen laut MEDLINE: COVID-19, Hyperglycemia, Hypoglycemia. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pontificia Universidad Católica del Ecuador.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop and validate a scoring system to predict mortality among hospitalized patients with COVID-19.

Methods

Retrospective cohort study. We analyzed 5,062 analyzed hospitalized patients with COVID-19 treated at two hospitals; one each in Quito and Guayaquil, from February to July 2020. We assessed predictors of mortality using survival analyses and Cox models. We randomly divided the database into two sets: (i) the derivation cohort (n = 2497) to identify predictors of mortality, and (ii) the validation cohort (n = 2565) to test the discriminative ability of a scoring system. After multivariate analyses, we used the final model’s β-coefficients to build the score. Statistical analyses involved the development of a Cox proportional hazards regression model, assessment of goodness of fit, discrimination, and calibration.

Results

There was a higher mortality risk for these factors: male sex [(hazard ratio (HR) = 1.32, 95% confidence interval (95% CI): 1.03–1.69], per each increase in a quartile of ages (HR = 1.44, 95% CI: 1.24–1.67) considering the younger group (17–44 years old) as the reference, presence of hypoxemia (HR = 1.40, 95% CI: 1.01–1.95), hypoglycemia and hospital hyperglycemia (HR = 1.99, 95% CI: 1.01–3.91, and HR = 1.27, 95% CI: 0.99–1.62, respectively) when compared with normoglycemia, an AST–ALT ratio >1 (HR = 1.55, 95% CI: 1.25–1.92), C-reactive protein level (CRP) of >10 mg/dL (HR = 1.49, 95% CI: 1.07–2.08), arterial pH 10 × 10 3 per μL (HR = 1.76, 95% CI: 1.35–2.29). We found a strong discriminative ability in the proposed score in the validation cohort [AUC of 0.876 (95% CI: 0.822–0.930)], moreover, a cutoff score ≥39 points demonstrates superior performance with a sensitivity of 93.10%, a specificity of 70.28%, and a correct classification rate of 72.66%. The LR+ (3.1328) and LR- (0.0981) values further support its efficacy in identifying high-risk patients.

Conclusion

Male sex, increasing age, hypoxemia, hypoglycemia or hospital hyperglycemia, AST–ALT ratio >1, elevated CRP, altered arterial pH, and leucocytosis were factors significantly associated with higher mortality in hospitalized patients with COVID-19. A statistically significant Cox regression model with strong discriminatory power and good calibration was developed to predict mortality in hospitalized patients with COVID-19, highlighting its potential clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HyperglycemiaHypoglycemiaHumansMaleAdolescentYoung AdultAdultRetrospective StudiesEcuadorRisk AssessmentHospitalsHypoxiaRisk Factors

Autor:innen und Institutionen

  • Instituto de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica del Ecuador (PUCE), Quito, Ecuador.
  • Escuela de Medicina, Facultad de Ciencias Médicas, de la Salud y de la Vida, Universidad Internacional del Ecuador, Quito, Ecuador.
  • Hospital General Norte de Guayaquil, IESS Ceibos, Instituto Ecuatoriano de Seguridad Social (IESS), Guayaquil, Ecuador.
  • Independent Researcher, Ecuador.
  • Hospital General del Sur de Quito, Instituto Ecuatoriano de Seguridad Social (IESS), Quito, Ecuador.

ORCID-Profile: Iván Dueñas-Espín, Hugo Espejo Cárdenas, Miguel Ochoa Andrade

Förderung

  • Pontificia Universidad Católica del Ecuador

Zitieren

APA

Dueñas-Espín, I., Echeverría-Mora, M., Montenegro-Fárez, C., Baldeón, M., Chantong Villacres, L., Espejo Cárdenas, H., Fornasini, M., Ochoa Andrade, M., & Solís, C. (2023). Development and validation of a scoring system to predict mortality in patients hospitalized with COVID-19: A retrospective cohort study in two large hospitals in Ecuador. PLOS ONE. https://doi.org/10.1371/journal.pone.0288106

Vancouver

Dueñas-Espín I, Echeverría-Mora M, Montenegro-Fárez C, Baldeón M, Chantong Villacres L, Espejo Cárdenas H, et al. Development and validation of a scoring system to predict mortality in patients hospitalized with COVID-19: A retrospective cohort study in two large hospitals in Ecuador. PLOS ONE. 2023. doi:10.1371/journal.pone.0288106

BibTeX
@article{DueasEspn2023,
  author = {Dueñas-Espín, Iván and Echeverría-Mora, María and Montenegro-Fárez, Camila and Baldeón, Manuel and Chantong Villacres, Luis and Espejo Cárdenas, Hugo and Fornasini, Marco and Ochoa Andrade, Miguel and Solís, Carlos},
  title = {Development and validation of a scoring system to predict mortality in patients hospitalized with COVID-19: A retrospective cohort study in two large hospitals in Ecuador},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0288106}
}
Kostenlos starten →